Back to 
Candriam S.C.A.
Candriam S.C.A.
RAPP2 quarters
Position history for Candriam S.C.A.'s holdings in RAPPORT THERAPEUTICS INC
Candriam S.C.A. holds 347,650 shares of RAPP (RAPPORT THERAPEUTICS INC), worth $14.5M as of 2026-Q2. The position was increased (+87.0% shares). RAPP represents 0.1% of Candriam S.C.A.'s portfolio.
Current Value
$14.5M
Current Shares
347,650
Total Value Change
+$8.7M
Total Shares Change
+161,725
Quarter-by-Quarter History
Other major holders of RAPP: FMR LLC, Capital International Investors